Integrated Core Strategies (Us) Llc - Sep 29, 2025 SCHEDULE 13G Report for BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
BTAI
Shares outstanding
19.8M shares
Disclosed Ownership
1.03M shares
Ownership
5.2%
Form type
SCHEDULE 13G
Date filed
10/1/2025, 04:15 PM
Date of event
Sep 29, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 5.2% 1.03M 0 1.03M /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 5.2% 1.03M 0 1.03M /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 5.2% 1.03M 0 1.03M /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 5.2% 1.03M 0 1.03M /s/ Israel A. Englander Israel A. Englander